Centrosomal Abnormalities in Pancreatic Cancer: Molecular Mechanisms and Clinical Implications

Research output: Contribution to journalReview article


The centrosome is the main microtubule-organizing center in human cells. It regulates normal cell-cycle progression and cell division. Aberrations in the number, structure and function of centrosomes have been found to drive genomic instability and tumorigenesis. Pancreatic cancer frequently displays centrosomal aberrations. Supernumerary and abnormal centrosomes are observed in the earliest stages of pancreatic tumor development, and the p53 pathway acts as an initial barrier to the proliferation of cells with extra centrosomes. In this review, we summarize recent advances in the understanding of centrosomal aberrations in pancreatic cancer, focusing on regulatory mechanisms and prospects for future anticancer treatment.


External organisations
  • Skåne University Hospital
  • Lund University
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cell and Molecular Biology
  • Cancer and Oncology


  • Centrosomal abnormalities, Molecular mechanisms, Pancreatic cancer, Review, Treatment
Original languageEnglish
Pages (from-to)1241-1245
JournalAnticancer research
Issue number3
Publication statusPublished - 2018 Mar 1
Publication categoryResearch